AI-powered
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
Study on Safety and Dosage Tolerance in Infants
Not Recruiting
1 years or below
All
Phase
N/A
1 Location
Brief description of study.
The purpose of this study is to evaluate the safety, dosing and tolerance in infants on the antibiotic rifampin.
Detailed description of study
The purpose of this study is to evaluate the safety, dosing and tolerance in infants on the antibiotic rifampin.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Bacterial Infection
-
Age: 1 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 1110007286
This study investigates the safety and appropriate dosing of an investigational medication in infants. The aim is to understand how infants tolerate this medication and to ensure it is safe for use.
Participants will undergo various procedures to monitor their health and response to the investigational medication. This may include regular health check-ups and laboratory tests to assess the medication's effects.
- Who can participate: Infants aged 0 to 12 months with parental consent are eligible. Participants should not have any known allergies to similar medications.
- Study details: Participants will receive the investigational medication, and their health will be monitored through regular check-ups and tests. A placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine, may be used for comparison.
